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It is well established that, over the course of development, hormones shape the vertebrate 
brain such that sex speciﬁ  c physiology and behaviors emerge. Much of this occurs in discrete 
developmental windows that span gestation through the prenatal period, although it is now 
becoming clear that at least some of this process continues through puberty. Perturbation of 
this developmental progression can permanently alter the capacity for reproductive success. 
Wildlife studies have revealed that exposure to endocrine disrupting compounds (EDCs), either 
naturally occurring or man made, can profoundly alter reproductive physiology and ultimately 
impact entire populations. Laboratory studies in rodents and other species have elucidated 
some of the mechanisms by which this occurs and strongly indicate that humans are also 
vulnerable to disruption. Use of hormonally active compounds in human medicine has also 
unfortunately revealed that the developing fetus can be exposed to and affected by endocrine 
disruptors, and that it might take decades for adverse effects to manifest. Research within the 
ﬁ  eld of environmental endocrine disruption has also contributed to the general understanding of 
how early life experiences can alter reproductive physiology and behavior through non-genomic, 
epigenetic mechanisms such as DNA methylation and histone acetylation. These types of 
effects have the potential to impact future generations if the germ line is affected. This review 
provides an overview of how exposure to EDCs, particularly those that interfere with estrogen 
action, impacts reproductive physiology and behaviors in vertebrates.
Keywords: bisphenol, genistein, soy, estrogen receptors, development, sexual differentiation
remains the subject of intense scrutiny and other determinants 
such as diet, stress, and body weight likely also play a role. At issue 
are both the degree to which low dose exposures to compounds 
with low hormonal potency can produce appreciable effects in the 
vertebrate reproductive system, and the difﬁ  culty of adequately 
assessing the potential long term risks of compounds with sex-, 
life stage-, and tissue-speciﬁ  c effects. Both issues are difﬁ  cult to 
address experimentally because the timing, duration and level of 
human exposure are often uncertain. Moreover, the latency between 
EDC exposure and the emergence of consequential health effects 
can be considerably long, even decades, and the degree to which 
gene-environment interactions can produce inter-individual vari-
ability is poorly understood. Finally, predicting human responses 
from sentinel wildlife cases and from in vitro and animal tests of 
endocrine action is not straightforward. Nonetheless, there is rea-
sonable and increasing evidence from in vitro and animal studies 
to suggest cause for concern. This review will address the poten-
tial long term physiological and behavioral effects of exposure to 
environmental endocrine disruptors in vertebrates, the evidence 
for human risk, and how this issue has transformed both endo-
crinology and toxicology.
An EDC is deﬁ  ned (in part) by the United States Environmental 
Protection Agency (EPA) as, “an exogenous chemical substance or 
mixture that alters the structure or function(s) of the endocrine 
system and causes adverse effects….at the level of the organism, its 
progeny, and populations or subpopulations of organisms.” This 
deﬁ  nition includes disruption of lactation, sexual maturation, the 
INTRODUCTION
Growing awareness of the prevalence of environmental compounds, 
both synthetic and naturally occurring, with endocrine disrupt-
ing properties has generated considerable debate among scientists, 
regulatory agencies, and the general public about the potential long-
term risks they pose for human and wildlife reproductive health. 
Is the endocrine disruption hypothesis plausible? Epidemiological 
evidence that human reproductive health is declining, particularly 
in Western nations, continues to mount. For example, sperm counts 
in Western countries appear to have declined by half in the past 
50 years (Carlsen et al., 1992; Swan et al., 2000). In Demark, it is 
now estimated that more than 10% of men have sperm counts in 
the infertile range and up to 30% are in the subfertile range (Joensen 
et al., 2008). There are also indications that female fecundity is 
declining, even among young women, although the rate and degree 
to which this is occurring has been difﬁ  cult to quantify (Brannian 
and Hansen, 2006; Frey and Patel, 2004; Nyboe Andersen and Erb, 
2006). Within the United States, median age at menarche, ﬁ  rst 
breast development, and sexual precocity has steadily advanced, 
especially among minority populations (Herman-Giddens et al., 
1997; Partsch and Sippell, 2001). Similar trends have been noted in 
Europe and among children adopted from developing countries by 
Western parents (Aksglaede et al., 2009; Parent et al., 2003; Proos 
et al., 1991). The cause is likely complex and multi-faceted, but 
rapidity of the increase in reproductive and behavioral disorders 
suggests an environmental component. Whether or not endocrine 
disrupting compounds (EDCs) could be a contributing factor 
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cases life threatening human diseases such as malaria. Others were 
devised as ﬂ  ame retardants, to kill weeds, or to make plastics harder, 
clearer, and more resistant to heat stress (bisphenol-a) or more 
pliable (the phthalates). Compounds produced in nature rather 
than by humans, such as the phytoestrogens, also ﬁ  t this deﬁ  ni-
tion (Figure 1).
DDT: THE FIRST KNOWN ENDOCRINE DISRUPTOR
The discovery that chemicals could interfere with the endocrine sys-
tem in non-target species was ﬁ  rst made by wildlife biologists who 
noted rapid population declines and abnormal reproductive physi-
ology and behavior in multiple species. For example, as early as the 
ability to produce viable, fertile offspring, sex speciﬁ  c behavior, and 
premature reproductive senescence. To date, the EPA has identiﬁ  ed 
hundreds of compounds that ﬁ  t this deﬁ  nition and thousands of 
others are suspected of having similar properties1 (Crisp et al., 1998; 
Toppari et al., 1996). Some of these compounds, such as oral con-
traceptives and a subset of pesticides, were speciﬁ  cally developed 
to target the endocrine system but the vast majority of chemicals 
on the EPA’s list were neither designed nor intended to, especially 
in mammals. Some, such as DDT or the pyrethrins were developed 
to kill mosquitoes and other pests that spread serious and in some 
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FIGURE 1 | Chemical structures and uses of common endocrine disruptors. DES, bisphenol-a and genistein are classiﬁ  ed as estrogen agonists while both of the 
phthalates are androgen antagonists. DDT is classiﬁ  ed as both an estrogen agonist and an androgen antagonist.
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1930s, famed Florida naturalist Charles Broley noticed   abnormal 
courtship behavior, reduced nesting behavior, and diminishing 
birth rates among numerous bird species all across the United States 
and Canada, most notably bald eagles. His behavioral observa-
tions ultimately led him to hypothesize that heavy consumption 
of ﬁ  sh tainted with the widely used pesticide dichlorodiphenyl-
trichloroethane (DDT) was sterilizing the birds (Beans, 1996). This 
contention launched an unprecedented investigation by scientists 
who both doubted and embraced his hypothesis. It was ultimately 
determined that DDT and its metabolites, although they did not 
cause sterility (sperm counts in the birds were normal), feminized 
male embryos, weakened eggshells, and interfered with reproduc-
tive behavior to such a signiﬁ  cant degree that it was decimating 
bird populations. These and similar cases were eloquently docu-
mented in the instant best selling book Silent Spring by Rachel 
Carsen (1962), the publication of which launched the modern 
environmental movement. She postulated that by liberally spray-
ing pesticides in our zealous determination to destroy “pests,” we 
were risking the systemic destruction of ourselves and our environ-
ment. This thesis fundamentally changed the public’s perception 
of pesticide use and a decade later, DDT was ultimately banned in 
the United States largely as a result of public pressure.
The dramatic DDT story demonstrated that exposure to a 
compound not designed to interact with the endocrine system 
could induce profound reproductive deﬁ  cits in non-target spe-
cies. Despite this however, the capacity for DDT and its metabolites 
to impact human health is still widely disputed, particularly when 
exposure occurs at “low levels” rather than through an industrial 
accident or other large scale mechanisms. At high doses DDT is a 
potent neurotoxin, but numerous studies in laboratory animals, 
and in vitro assays have established that at low doses it can act as 
an endocrine disruptor. Even though DDT is no longer used in 
the US, human exposure to DDT and its metabolites is ongoing. 
For example, the primary metabolite of DDT, DDE, is far more 
persistent than the parent compound and thus still found in the 
environment at low levels. It is also highly lipophilic and accumu-
lates in fat, so body burden increases with age. In addition, DDT 
is still used in many parts of the world, especially where the risk of 
contracting malaria, a disease which kills more people than cancer, 
heart disease or the HIV virus, is great. According the World Health 
Organization (WHO) nearly a million people died of malaria in 
2006, 91% of them children2. In contrast, no one is known to have 
died from routine DDT use. Whether or not DDT can induce dis-
ease or impair reproductive development in humans remains the 
subject of investigation and a controversial topic. A recent epide-
miology study associated in utero or neonatal exposure with an 
increased risk of breast cancer (Cohn et al., 2007) a study which 
adds to a body of literature suggesting that prepubertal exposure 
to DDT may increase the risk of breast cancer (Clapp et al., 2008). 
Unfortunately many of the epidemiological studies exploring a 
potential association between DDT exposure and breast cancer 
risk have methodological weakness which make the data difﬁ  cult to 
interpret, and many scientists remain skeptical that DDT exposure 
is a causative factor for breast cancer development (Beard, 2006). 
Emerging evidence from areas where DDT is still used suggests 
that DDT exposure might also be associated with other diseases 
including preterm birth, early pregnancy loss, reduced semen qual-
ity, disrupted menstruation, and problems with lactation (Beard, 
2006; Rogan and Chen, 2005; Venners et al., 2005). But other  factors, 
such as unreliable access to clean water and adequate nutrition are 
potential confounds and birth rates in these areas remain high. 
Nursing infants from these regions are frequently exposed to levels 
in breast milk which exceed the acceptable daily intake of 20 µg/kg 
body weight per day established by the WHO. Therefore the poten-
tial reproductive risk of DDT exposure is ongoing for many popu-
lations outside the US.
DDT, its metabolites, and the majority of other endocrine dis-
ruptors are now known to affect the endocrine system by multiple 
mechanisms, most notably by acting as weak estrogen agonists. 
Thus, the hypothesis that endocrine disruption is a signiﬁ  cant 
health concern for humans would be strengthened by the demon-
stration that exposure to synthetic estrogens, particularly early in 
development, can have lasting effects. Unfortunately, this link has 
already been made.
EVIDENCE OF THE POTENTIAL FOR ESTROGENIC ENDOCRINE 
DISRUPTORS TO AFFECT HUMAN HEALTH
The clearest evidence that exposure to estrogen during fetal devel-
opment can impact human reproductive health emerged from the 
widespread use of the potent synthetic estrogen diethylstilbestrol 
(DES, Figure 1). Beginning in 1938, DES was initially prescribed 
to prevent miscarriage but ultimately advertised and dispensed to 
pregnant women in general to produce “stronger babies” and even 
administered to newborns to enhance weight gain (Karnaky, 1953; 
Kuchera, 1971; Palmlund, 1996; Smith, 1948). It is estimated that 
DES was taken by four to six million (and possibly as many as 10 
million) pregnant women in the US alone before human use was 
suspended in 1971 (Giusti et al., 1995). Non-medical use of DES 
was also common and thus a signiﬁ  cant source of DES exposure, 
albeit in lower does. For example, it was frequently used in cosmet-
ics, lotions, shampoo, and as a growth promoter in chicken and 
cattle. DES implants in poultry were outlawed in 1959 when DES 
residues were found in chicken liver, however this did not affect 
the use of DES in cattle, which remained ubiquitous until it was 
ultimately phased out in 1979. By the 1980s, more than 80% of 
US cattle were estimated to have been exposed, and considerable 
release of DES into the environment through feed lots and cat-
tle waste has been well documented (Metzler, 1981; Zervos and 
Rodricks, 1982).
Unfortunately DES was ineffective at preventing miscarriage 
(Dodds et al., 1938) but the reproductive consequences to the devel-
oping offspring (both male and female) would ultimately prove 
to be extensive. One consequence of in utero DES exposure was 
ﬁ  rst identiﬁ  ed in 1971 by a group of keen eyed physicians who 
noticed that girls born to mothers who took DES during pregnancy 
(collectively referred to as “DES daughters”) were more likely to 
develop an extremely rare type of cervicovaginal clear-cell adeno-
carcinoma (CCAC) (Herbst et al., 1970, 1971). One in 1000 DES 
daughters is now estimated to have developed CACC by the age 
of 34 (Giusti et al., 1995; Rubin, 2007) which is an extraordinar-
ily high rate for such a rare form of cancer. DES exposure is also 
associated with increased incidences of vaginal dysplasia, vaginal  2http://apps.who.int/malaria/wmr2008/malaria2008.pdfFrontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  4
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and cervical adenosis and abnormalities of the cervix, vagina, and 
uterus. DES daughters suffer from reduced fertility, a higher risk 
of infertility, and more complicated and unsuccessful pregnancies. 
Complications include ectopic pregnancy, late spontaneous abor-
tions and premature delivery (Palmlund, 1996; Palmlund et al., 
1993). Increased rates of psychiatric disorders including depression, 
anorexia, phobias and learning disabilities have also been reported 
(Vessey et al., 1983). Damage from DES exposure is not limited 
to females. DES sons are also affected and show elevated rates of 
urogenital malformations, undescended testes, and testicular can-
cer. Low sperm density and mobility has also been observed (Gill 
et al., 1976; Palmer et al., 2005; Stenchever et al., 1981; Wilcox et al., 
1995).
Most of the reproductive outcomes following fetal exposure to 
DES were predicted by or replicated in animal models (McLachlan 
et al., 1982; Newbold, 2008; Newbold and McLachlan, 1982). Thus, 
this unfortunate event in human medical history illustrates both 
the vulnerability of the developing fetus to estrogenic endocrine 
disruptors and the importance of animal models for predicting 
potential adverse effects in humans. Similarly, experimental work 
in multiple species was equally critical for establishing a causal 
link between DDT exposure and abnormal reproductive behav-
ior accompanied by compromised fertility in wildlife populations 
(Beans, 1996; Guillette and Gunderson, 2001; Toppari et al., 1996). 
Therefore the importance of animal models in human risk assess-
ment paradigms should not be underappreciated.
KEY CONCEPTS OF ENDOCRINE DISRUPTION: TIMING, DOSE 
AND NONLINEAR EFFECTS
The impact of the DES tragedy on the ﬁ  eld of toxicology was 
transformative and three key principles of endocrine disruption 
emerged. First, the latency between fetal insult and the manifesta-
tion of physical or behavioral dysfunction can be extremely long, 
even decades. This concept had long been recognized by behavioral 
endocrinologists including Beach, Young, Goy and others explor-
ing the mechanisms by which fetal hormone exposure could alter 
sexual behavior and sex speciﬁ  c neuroendocrine feedback systems 
(Balthazart et al., 1996; Gorski, 1963; Goy and Resko, 1972; Marler, 
2005; Swaab and Hofman, 1984; Young et al., 1964), but was a 
breakthrough for toxicologists. It is now the basis for a conceptual 
framework termed the “fetal basis of adult disease,” an idea that 
has transcended the endocrine disruption ﬁ  eld. The concept that 
exposure to environmental factors, including toxicants, during fetal 
or neonatal life can interact with the genome and inﬂ  uence diseases 
which emerge years later including cancer, infertility, precocious 
puberty and obesity is potentially revolutionary and is currently a 
“hot topic” of research.
A second key concept of endocrine disruption is that the dose 
response of many hormones and EDCs appears to be nonmonot-
onic. This paradigm is anathema to the fundamental toxicological 
principle that “the dose makes the poison.” The standard approach 
in toxicology, for experiments looking at acute exposure, is to 
expose either cells or animals to a few, generally high, concentra-
tions of a given chemical. Selection of those doses is traditionally 
based on one of two standardized measurements called the LD50, 
which is the dosage lethal to 50% of the exposed organism or cells, 
and the lowest observed effect concentration (LOEC), which is the 
 lowest concentration that produces readily observable morphologi-
cal deformities. Similar designs using high (often near-lethal) doses 
that are not considered environmentally relevant are frequently 
used for subchronic and chronic exposure studies as well. These 
approaches assume that adverse effects increase proportionally and 
predictably with exposure level (generally linear or sigmoidal) and 
there is a threshold below which no effect is observed (termed the 
no observable adverse effect level or NOAEL). A level 1000-fold 
lower is then deemed the “safe” or “reference dose” for humans. 
With this model, potential low dose effects can be extrapolated 
from studies where doses in the range of the LD50 (or LOEC) are 
used. It also assumes that the observed effects will be obvious and 
include readily appreciable abnormalities. Unfortunately, there 
is growing evidence to suggest that the effects produced by hor-
mones and many endocrine disruptors are not adequately predicted 
by this model because they have nonmonotonic dose responses 
that more closely approximate a U-shaped or inverted U-shaped 
curve (Andersen et al., 1999; Hayes et al., 2002; Sheehan, 2006; 
Vandenberg et al., 2006). In addition, effects, as seen with DES 
and CCAC, are likely to be more insidious and thus potentially dif-
ﬁ  cult to readily identify. It is unclear how compounds can produce 
U-shaped dose effects but this response likely reﬂ  ects an integration 
of two different mechanisms of action, each of which occurs at a 
different dose range (Vandenberg et al., 2009). Thus a compound 
like DDT could potentially interfere with estrogen (or androgen) 
action at low doses but act as a potent neurotoxin at levels closer 
to the LD50 (Toppari et al., 1996). It should be noted that although 
some toxicologists have expressed concern that nonmonotonic dose 
responses are underappreciated (Calabrese, 2001; Calabrese and 
Baldwin, 2003), others doubt their existence (Crump, 2001) and 
the concept remains highly contentious (Lutz et al., 2005; Melnick 
et al., 2002; Vandenberg et al., 2009).
A ﬁ  nal principle of endocrine disruption made evident by the 
DES story is that the timing of exposure is crucial. The presence and 
extent of disorders common to DES sons and daughters varies sub-
stantially depending on the timing of the mother’s ﬁ  rst exposure, 
total dose, and length of exposure (Faber et al., 1990; Robboy et al., 
1981, 1984). In humans and animals, there are critical windows of 
development, both for the reproductive organs and the brain, when 
sensitivity to hormones and EDCs is heightened. Again, this was 
not a novel concept to neuroendocrinologists but was previously 
underappreciated by toxicologists. Within this concept is also the 
recognition that the placenta is not impenetrable to EDCs and 
that, on the contrary, most EDCs likely reach the developing fetus. 
Maternal estrogens are effectively sequestered by α- fetoprotein 
but most estrogen-like compounds only weakly or fail to bind to 
α-fetoprotein and can therefore enter fetal circulation relatively 
unimpeded (Ikezuki et al., 2002; Milligan et al., 1998; Vandenberg 
et al., 2007). It is now widely accepted that development is a window 
of exceptional vulnerability to EDC exposure.
ORGANIZATION OF REPRODUCTIVE NEUROENDOCRINE 
CIRCUITS
During early development (gestation in humans, gestation and 
early neonatal life in rodents), the neuroendocrine feedback loops 
which regulate sex-speciﬁ  c reproductive physiology and behav-
ior are sexually differentiated and organized. The coordination Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  5
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of physiological events and appropriate behavioral responses to 
them is paramount to reproductive ﬁ  tness and the stability of a 
  population. For example, the reproductive ﬁ  tness of an   ovulating 
female that fails to mate or nurse her young is just as dimin-
ished as the reproductive ﬁ  tness of a female that fails to ovulate. 
Similarly, a male who responds to a soliciting female with aggres-
sion rather than courtship has a signiﬁ  cantly decreased chance of 
passing along his genome even if he is physiologically capable of 
doing so. Thus, populations can be at risk when the integration 
of behavioral responses to physiological and environmental cues 
is disrupted. The organization of the neuroendocrine circuits that 
coordinate sex-speciﬁ  c physiology and behavior is orchestrated 
largely by steroid hormones, particularly estrogen, during distinct 
critical periods in embryonic and postnatal development (Cooke 
et al., 1998; Gorski, 1985; Simerly, 1998, 2002). The organization 
of these circuits appears to be particularly vulnerable to disrup-
tion by EDCs.
Maturation and function of the vertebrate reproductive system 
is coordinated by the hypothalamic-pituitary-gonadal (HPG) axis. 
This system encompasses a complex network of neuronal signaling 
pathways that enable the regulation of gonadotropin secretion by 
steroid hormones (Elkind-Hirsch et al., 1981; Gorski et al., 1975). 
The neural components of the HPG axis span multiple brain areas, 
primarily the hypothalamus, a diencephalic region important for 
coordination of many neuroendocrine functions including hunger, 
thirst, circadian cycles, emotion, body temperature and stress in 
addition to reproduction. It is responsive to a litany of external 
signals including day length, hormones, olfactory cues, and glucose 
levels, among others. Contained within the hypothalamus are dis-
crete populations of neurons that regulate gonadotropin releasing 
hormone (GnRH) secretion. The network of regulatory inputs from 
neuronal and glial cells in the brain projecting to these neurons is 
sexually differentiated by endogenous gonadal hormones (prima-
rily estradiol in rodents but perhaps both estrogens and androgens 
in humans) through a series of gestational, pre- and perinatal criti-
cal periods (Cooke et al., 1998; Gorski, 1985; Simerly, 1998, 2002). 
In the post-pubertal animal, GnRH release is regulated through 
feedback effects of gonadal steroids. In both males and females, 
GnRH secretion is suppressed by steroid negative feedback, the 
signal for which is thought to arise from the arcuate nucleus (ARC) 
of the hypothalamus (Kauffman et al., 2007b; Tena-Sempere, 2006). 
In females, however, GnRH release is augmented once per cycle by 
estrogens. This positive feedback potentiates the surge in GnRH 
and, subsequently, luteinizing hormone (LH) that precedes ovu-
lation (Clarke and Pompolo, 2005). This process is now thought 
to be mediated within the anterior hypothalamus (Adachi et al., 
2007; Kauffman et al., 2007b; Tena-Sempere, 2006) and the sex 
speciﬁ  c organization of this system can be manipulated, induc-
ing long term consequences. For example, it is well established 
that the administration of steroid hormones, including androgens 
or estrogens, during the neonatal critical period can masculinize 
the female rodent brain while castration can effectively prevent 
defeminization of the male rodent brain (Bakker and Baum, 2008; 
Baum, 1979; Simerly, 2002). Thus, in males castrated as neonates, 
the potential for estrogen to evoke a GnRH surge is preserved while, 
conversely, in females neonatally exposed to estrogens, this capacity 
is diminished or lost.
The neuroendocrine pathways regulating reproductive behavior 
are similarly organized and affected by steroid hormones. In rats, 
lordosis is a reﬂ  exive receptive posture made by the female in 
response to male mounting and is a hallmark indication of sexual 
receptivity. Whereas circulating estrogens play an essential role in 
stimulating lordosis in females (Davidson and Bloch, 1969; Lisk, 
1969; Komisaruk and Diakow, 1973; Pfaff, 1999; Pfaff and Sakuma, 
1979), males rarely display lordosis behavior even after estro-
gen administration in adulthood (Yamanouchi and Aria, 1976). 
However, neonatal steroid hormone manipulation can retain in 
the capacity to evoke lordosis in males, and suppress proceptive 
behavioral displays by females, indicating that sex-speciﬁ  c behav-
iors are also organized by steroid hormones in the perinatal period 
(Gerall, 1967; Gorski, 1963, 1985; Grady et al., 1965; Sodersten, 
1978; Patisaul et al., 2009a; Whalen and Nadler, 1963; Whales et al., 
1986). Thus, aberrant organization of sex speciﬁ  c neuroendocrine 
circuits can have profound and permanent effects on sex speciﬁ  c 
reproductive physiology and behavior. Consequently, the organiza-
tion of neuroendocrine pathways is considered to be particularly 
vulnerable to endocrine disruption. Most examples detailed within 
this review result from endocrine disruption of the neuroendocrine 
system.
LOW DOSE EFFECTS: HEALTH RISK OR HYPE?
It is now evident that exposure to endocrine disruptors has the 
potential to adversely affect reproductive physiology and behavior 
in vertebrates. The critical question now is if wildlife and human 
health is at risk from chronic exposure to low doses of these com-
pounds, either alone or in mixtures. DDT was applied liberally and 
has a long half life, thus affected wildlife populations had relatively 
high exposure levels. Moreover, DES has a binding afﬁ  nity for ERα 
and ERβ that is roughly equivalent to estradiol and is therefore a 
potent estrogen agonist (Korach et al., 1978; Sadler et al., 1998). 
Most endocrine disruptors exist at far lower levels in the environ-
ment and have binding afﬁ  nities 100–10,000 times lower than either 
estradiol or DES. In some cases, however, blood levels of these 
compounds can be several fold higher than endogenous estrogen 
levels and suspected endocrine disruptors are almost always present 
in both the environment and in bodily ﬂ  uids as mixtures. Although 
DDT and many other EDCs are classiﬁ  ed as “weak estrogens” the 
precise mechanisms through which they interact with the verte-
brate neuroendocrine system and the exposure levels that produce 
substantive effects are still largely undetermined. For example, DDT 
(and its metabolites) is now appreciated to act as both an estrogen 
agonist and an androgen antagonist highlighting the potential for 
compounds to have multiple mechanisms of action. Direct binding 
to steroid receptors is only one mode of action. Endocrine disrup-
tion also includes interference with the biosynthesis, transport, or 
metabolism of hormones or the disruption of the recruitment of 
binding proteins or transcription factors. Another key issue that 
remains poorly understood is how these compounds behave within 
mixtures. Wildlife and human populations are exposed to dozens if 
not hundreds of compounds simultaneously yet very little is known 
about how these compounds interact either in vitro or in vivo.
For simplicity, to address the question of whether or not endo-
crine disruptors have the potential to affect reproductive physiology 
and behavior at low doses, this review will focus on three compounds Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  6
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but is consistently high among soy foods, averaging near 40 µg total 
isoﬂ  avones per gram of formula (Franke et al., 1998b; Johns et al., 
2003; Setchell and Welsh, 1987; Setchell et al., 1997). This translates 
to a daily intake of approximately 6–9 mg/kg body weight per day, 
an amount, when adjusted for body weight, which is four to seven 
times higher than the amount consumed by adults on a traditional 
soy-based Asian diet or meeting the FDA guidelines (Barnes, 1995) 
and considerably higher than any synthetic EDC.
So is there cause for concern? The sheep and cheetah cases are 
disquietingly similar to the bird and other wildlife studies of the 
1970s which ultimately identiﬁ  ed the endocrine disrupting proper-
ties of DDT. But even today the question of whether or not DDT 
can impact human health is controversial, and such is the case 
with soy phytoestrogens. Is there any reasonably good evidence 
that phytoestrogens can have long term adverse health effects in 
humans following developmental exposure? A pair of studies on 
Puerto Rican girls associated neonatal phytoestrogen exposure with 
advanced pubertal onset, but a number of confounding factors 
including the use of potent estrogens in meat production, make 
the data problematic and difﬁ  cult to interpret (Freni-Titulaer et al., 
1986; Schoental, 1983). A more recent, retrospective cohort study 
found that young women fed soy-based infant formula as part 
of a controlled, University of Iowa feeding study reported longer 
menstrual bleeding and menstrual discomfort than those who were 
fed a non-soy based formula as babies (Strom et al., 2001). Beyond 
these epidemiology studies, very little is known about how exposure 
to soy phytoestrogens, either in the womb or in infancy, impacts 
female reproductive health or behavior in humans.
Data from animal research is more abundant. Neonatal expo-
sure to genistein advances pubertal onset, increases the length of 
the estrous (menstrual) cycle and hastens the onset of persistent 
estrus in rodents. Female mice treated with 0.5–50 mg/kg genistein 
for only the ﬁ  rst 5 days of life give birth to fewer live pups over 
time compared to untreated control animals, with fertility most 
strongly impacted at the highest dose (Jefferson et al., 2005). This 
acceleration of reproductive senescence could result from disrup-
tion anywhere within the HPG axis including the ovary and brain. 
Detailed work in mice by Jefferson and colleagues has revealed 
that genistein can interfere with ovarian differentiation resulting 
in ovarian malformations indicative of impaired fecundity such as 
multi-oocyte follicles, and attenuated oocyte cell death (Jefferson 
et al., 2002, 2006, 2007). Ovarian defects, including the absence of 
corpora lutea, the presence of large antral-like follicles with degen-
erating or no oocytes and numerous ovarian cysts have also been 
observed following neonatal genistein exposure in rats (Kouki et al., 
2003) (Figure 2).
Recent studies in our laboratory have found that the organization 
of sexually differentiated neural pathways within the hypothalamus 
is also vulnerable to neonatal endocrine disruption by genistein. 
We determined that advanced vaginal opening and abnormal 
estrous cyclicity, induced by neonatal exposure to 10 mg/kg gen-
istein, is accompanied by an impaired ability to stimulate GnRH 
neuronal activity (as measured by the immunoreactivity of both 
of GnRH and Fos) following ovariectomy and hormone priming 
(Bateman and Patisaul, 2008) (Figure 3). This observation indi-
cates that neonatal genistein exposure has a masculinizing effect 
on the female HPG axis. Although GnRH neurons express ERβ 
currently gaining wide scientiﬁ  c and public attention: genistein, 
bisphenol-a (BPA) and the phthalates. genistein and BPA are clas-
siﬁ  ed as weak estrogen agonists and thus   presumably have   similar 
mechanisms of action (Figure 1). However, genistein, because it is 
produced by plants and found in soy foods, is widely perceived as 
healthful while BPA, a component of polycarbonate plastics and 
epoxy resins, is commercially produced and was recently classiﬁ  ed 
as a toxin in Canada (April, 2008). These attitudes are incongruous 
if the two compounds indeed elicit similar effects and therefore 
warrant further comparative investigation. The phthalates are found 
in a wide variety of products including cosmetics, pharmaceuticals, 
toys and medical devices. They are classiﬁ  ed as androgen antagonists 
and their use was recently restricted in the US.
GENISTEIN AND FEMALE REPRODUCTIVE PHYSIOLOGY
The endocrine disrupting potential of phytoestrogens was ﬁ  rst 
noticed in Australia in the 1940s when abnormally high rates of infer-
tility, abortion, and reproductive abnormalities in newborn lambs 
were observed in ewes grazing on clover rich pastures (Bennetts and 
Underwood, 1951; Bennetts et al., 1946). It was ultimately deter-
mined that the steroid-like ﬂ  avonoid phytoestrogens, most nota-
bly coumestrol, were responsible for the observed effects (Adams, 
1995a,b; Braden et al., 1967). Decades later, a singular case of infertil-
ity and liver disease in captive cheetahs placed on a soy-based diet 
was ultimately attributed to the same class of compounds (Setchell 
et al., 1987). These incidents are reminiscent of the DDT story in wild 
bird populations, and have raised questions regarding the potential 
risk ﬂ  avonoid phytoestrogens might pose to humans.
The two major classes of phytoestrogens are the lignans and 
the isoﬂ  avonoids. Lignans are minor components of cell walls and 
the highest concentrations are found in ﬂ  axseed (linseed) prod-
ucts, pumpkin seeds, green tea, coffee, and other ﬁ  ber-rich foods 
(Axelson et al., 1982; Kuhnle et al., 2008; Mazur and Adlercreutz, 
2000; Penalvo et al., 2008; Thompson et al., 1991, 2006). The iso-
ﬂ  avonoids are most prevalent in legumes, especially soybeans and 
soy-based foods including soy infant formula, tofu and soy milk, 
but detectable levels also occur in fruits, vegetables, whole grains, 
and even some alcoholic beverages (Adlercreutz and Mazur, 1997; 
Fletcher, 2003; Franke et al., 1998a; Lapcik et al., 1998; Reinli and 
Block, 1996; Setchell et al., 1998). Dietary supplements containing 
high levels of isoﬂ  avonoid phytoestrogens are now widely available 
(Setchell et al., 2001). Of the many isoﬂ  avonoids found in soy, the 
most intensely scrutinized are genistein and daidzein.
Considerable attention is now being paid to the potential 
endocrine disrupting properties of isoﬂ   avonoids because soy 
consumption is widely promoted as being healthful and has been 
associated with reduced risk of cardiovascular disease and hormone 
dependent cancers (Adlercreutz and Mazur, 1997; Clarkson, 2002; 
Demonty et al., 2003; Peeters et al., 2003). In 1999, the US Food 
and Drug Administration (FDA) approved the health claim that 
daily consumption of 25 g of soy protein can reduce the risk of 
coronary artery disease (Food and Drug Administration, 1999). Soy 
consumption is increasing among all age groups, especially infants 
and children (Cao et al., 2009; Setchell, 2001; Strom et al., 2001). 
Genistein and other phytoestrogens readily cross the placenta indi-
cating that fetal exposure is also potentially consequential (Todaka 
et al., 2005). Total isoﬂ  avone content in soy infant formula varies Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  7
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throughout development (Herbison and Pape, 2001; Hrabovszky 
et al., 2000, 2001) and thus could potentially respond to   neonatal 
genistein directly, it is generally accepted that hormonal and other 
environmental signals are largely conveyed to GnRH neurons from 
other estrogen-responsive neurons clustered in different regions 
of the hypothalamus. In rodents, the two most signiﬁ  cant regions 
appear to be the anterior ventral periventricular (AVPV) and 
  arcuate (ARC) nuclei (Gu and Simerly, 1997; Polston et al., 2004; 
Polston and Simerly, 2006; Shughrue et al., 1997; Simerly et al., 
1990) both of which contain sexually dimorphic populations of 
neurons that express the KiSS-1 gene. This gene codes for a family 
of peptides called kisspeptins (previously called metastins), and 
rapidly emerging evidence indicates that kisspeptin neurons are 
essential for   coordinating pubertal onset and steroid feedback on 
GnRH neurons in many species, including humans (Kauffman et al., 
2007a; Navarro et al., 2004; Smith et al., 2006a,b). AVPV kisspeptin 
neurons are more numerous in females than males and are thought 
to be essential for steroid positive feedback and the initiation of 
the preovulatory GnRH surge (Clarkson et al., 2008; Gottsch et al., 
2004; Irwig et al., 2004; Kauffman et al., 2007a, Roa et al., 2006; 
FIGURE 2 | Frequently observed ovarian malformations in rats following 
neonatal exposure to endocrine disruptors. (A) An ovary from an unexposed 
adult female contains follicles at all stages of folliculogenesis and numerous 
corpora lutea (CLs), indicative of successful ovulation. (B) Ovaries from females 
neonatally treated with the synthetic estrogen estradiol benzoate (25 µg) show 
no signs of folliculogenesis, are undersized and lack CLs. The presence of 
numerous, large antral-like follicles (AF) most of which contain a degenerating or 
no oocyte and are frequently reminiscent of ovarian cysts, are commonly 
observed following neonatal exposure to (C) BPA (50 mg/kg bw) or (D) genistein 
(10 mg/kg bw). CLs are often absent or signiﬁ  cantly reduced in number when 
numerous AFs are present. A multi-oocyte follicle (E) in a pre-pubertal ovary 
following neonatal treatment with estradiol benzoate (10 µg).Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  8
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Smith et al., 2006b). In contrast, KiSS mRNA expression in the ARC 
is not thought to be sexually dimorphic and appears to be important 
for the regulation of steroid negative feedback (Kauffman et al., 
2007a). We have now shown that neonatal exposure to 10 mg/kg 
genistein can signiﬁ  cantly decrease the density of neuronal ﬁ  bers 
immunolabeled for kisspeptin in the AVPV but not the ARC of 
female rats (Bateman and Patisaul, 2008; Patisaul et al., 2009b) 
indicating that disrupted organization of the kisspeptin signaling 
pathways may be a novel yet fundamental mechanism by which a 
suite of reproductive abnormalities are induced including disrupted 
timing of pubertal onset, irregular estrous cycles and premature 
anovulation.
Interestingly, animals exposed to genistein neonatally remained 
capable of displaying lordosis when ovariectomized, primed by the 
sequential administration of estradiol benzoate and progesterone, 
and paired with vigorous males (Figure 3). Lordosis behavior is 
also retained by female rats neonatally exposed to agonists selective 
for either ERα or ERβ but not estradiol benzoate suggesting that 
agonism of both ER subtypes may be needed to fully defeminize 
the behavior (Patchev et al., 2004; Patisaul et al., 2009a). It may also 
take a longer exposure or higher doses, a possibility which illustrates 
the important concepts of dose and timing when considering the 
potential effects of EDCs. Further complicating the issue is a report 
that selective agonism of ERβ results in a statistically signiﬁ  cant 
reduction, but not elimination, of lordosis behavior in mice (Kudwa 
et al., 2006). This could be a species difference in sensitivity or the 
relative role ERβ plays in the organization of the neuroendocrine 
pathways that mediate the lordosis response. Further work will be 
needed to clarify this issue.
The mechanisms by which genistein and the other phytoestro-
gens inﬂ  uence sex-speciﬁ  c physiology are likely diverse. Genistein 
has a higher relative binding afﬁ  nity for both ERα and ERβ in vitro 
than most other EDCs and a higher binding afﬁ  nity for ERβ that 
for ERα (Kuiper et al., 1998). Genistein is also a potent inhibitor 
of tyrosine protein kinases (Boutin, 1994; Piontek et al., 1993), 
which catalyze phosphorylation of their own tyrosine residues 
and those of other proteins, including growth factors involved 
in tumor cell proliferation. In addition, genistein can also inhibit 
DNA topoisomerases I and II, enzymes essential for DNA repli-
cation (Kurzer and Xu, 1997; Okura et al., 1988) and may also 
work through epigenetic mechanisms involving both hyper and 
hypomethylation (Dolinoy et al., 2006; Tang et al., 2008). A further 
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FIGURE 3 | Effects of neonatal exposure to genistein (GEN, 10 mg/kg bw) 
compared to an oil based vehicle (OIL), and estradiol benzoate (EB, 50 µg) 
on reproductive physiology and behavior in female rats. (A) GEN 
signiﬁ  cantly advanced the timing of pubertal onset as measured by day of 
vaginal opening compared to control females. (B) This corresponded with 
anovulation (by 15 weeks of age) in 43% of GEN females, compared to 
none of the OIL females and all of the EB females. (C) There was no effect 
of GEN on sexual receptivity (following ovariectomy and hormone priming) 
however (D) the number of GnRH neurons also immunopositive for Fos 
was signiﬁ  cantly reduced indicating an impaired capacity to display 
steroid positive feedback. (Panels (A) and (D) adapted from Bateman 
and Patisaul, 2008).Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  9
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onset of ﬁ  rst estrus indicating advanced puberty (Adewale et al., 
(in press); Honma et al., 2002). Ovarian malformations includ-
ing increased number of blood-ﬁ  lled ovarian bursae, indicative 
of advanced   reproductive aging, abnormal numbers of antral fol-
licles, aneuploidy and decreased corpora lutea (Figure 2) have also 
been observed by us and others (Adewale et al., (in press); Markey 
et al., 2003; Susiarjo et al., 2007). BPA can also induce apoptosis 
and cell arrest in cultured ovarian granulosa cells (Xu et al., 2002). 
Prolonged, irregular estrus cycles are also frequently observed by 
us and others following perinatal exposure to low doses suggest-
ing compromised fertility (Adewale et al., (in press); Markey et al., 
2003). Mammary gland development appears to be particularly 
sensitive to BPA at multiple points in the life span including embry-
onic development, the perinatal period, puberty and adulthood 
(Markey et al., 2001, 2003; Wadia et al., 2007), effects which may be 
mediated by an ERα-dependent mechanism (Recchia et al., 2004; 
Vivacqua et al., 2003). Defects include intraductal hyperplasias, 
increased sensitivity to endogenous estradiol and the development 
of neoplastic lesions (Durando et al., 2007).
Like genistein, BPA may also compromise sexual differentia-
tion in the brain. We determined that exposure to 500 µg BPA for 
only 2 days, beginning the day after birth, feminized the number 
of dopaminergic neurons in the pubertal male rat AVPV (Patisaul 
et al., 2006) but not the overall size of the AVPV (Patisaul et al., 
2007). Another laboratory subsequently reported decreased num-
bers of dopaminergic neurons in the AVPV of female mice exposed 
from gestation through lactation to lower, environmentally relevant 
doses (Rubin et al., 2006). Collectively, these studies suggest that 
each sex may be susceptible to different doses, a hypothesis that 
is intriguing and merits further exploration as the observed dis-
crepancy could also be due to differences in, route of administra-
tion, duration of exposure or species; all of which illustrates the 
challenge of translating animal data to human risk assessments. 
Notably, other studies have also reported phenotypic changes in 
the AVPV after neonatal exposure to EDCs (Gore, 2008). Exposure 
to Aroclor 1221, a mixture of PCBs, through late gestation and the 
early neonatal period reduced the number of ERβ-expressing cells 
in the adult female rat AVPV without markedly affecting volume 
(Salama et al., 2003). Similarly, exposure to 2,3,7,8-tetrachlorod-
ibenzo-p-dioxin (TCDD) on gestational day 15 abolished the sexu-
ally dimorphic expression of GAD 67 in the rat AVPV on PND 3 
(Hays et al., 2002). Although these data support the hypothesis 
that sexual differentiation of the brain in general, and within the 
AVPV speciﬁ  cally, may be vulnerable to endocrine disruption, the 
physiological and functional consequences of these changes has 
yet to be convincingly established.
Considerable scientiﬁ  c debate remains about whether or not 
humans are exposed to truly signiﬁ  cant levels of BPA. Human serum 
levels have generally been found to be in the range of 0.2–20 ng/ml 
(Vandenberg et al., 2007) and urinary levels increase following the 
consumption of beverages from polycarbonate bottles contain-
ing BPA (Carwile et al., in press). Most rodent studies evaluating 
potential adverse effects of BPA did not measure serum levels in 
exposed animals making it difﬁ  cult to determine if the outcomes 
can be extrapolated to humans. Further complicating the issue is 
that humans and rodents metabolize BPA differently, however both 
species, along with non-human primates, exhibit comparable levels 
complication is the observation that effects of genistein admin-
istration at low doses are compounded when co-administered 
with other EDCs (Kurzer and Xu, 1997; You et al., 2002). Mixture 
effects of phytoestrogens, as with most other EDCs, are generally 
unappreciated.
BISPHENOL-A (BPA): A DYNAMIC AND ONGOING 
CONTROVERSY
BPA is somewhat unique among EDCs because, in the early twen-
tieth century, it was being developed as a possible synthetic estro-
gen (a pursuit which was abandoned following the synthesis of 
DES) (Dodds and Lawson, 1936). Since the 1950s, it has been used 
primarily in the production of polycarbonate plastic products to 
improve clarity and increase resilience. It is also a component of 
epoxy resins used to line the interior of metal cans such as soda 
and soup cans. Human exposure to BPA occurs through every-
day use of these items because it can migrate from the container 
into the contents, especially when heated (Brede et al., 2003). The 
United States Centers for Disease Control recently estimated that 
nearly all Americans have detectable levels of BPA in their bodies, 
with children having higher levels than adults (Calafat et al., 2005, 
2008). Infants in neonatal intensive care units have particularly high 
exposure to BPA, presumably from its use in medical devices and 
from the migration of BPA into infant formula from the container 
(Calafat et al., 2009). In addition, newborns can be exposed through 
lactational transfer (Tsutsumi, 2005) and relatively high levels in 
umbilical cord blood and fetal serum (compared to maternal blood 
levels) indicate that BPA fails to bind α-fetoprotein and can expose 
the developing fetus (Ikezuki et al., 2002; Vandenberg et al., 2007). 
Exposure to BPA is not limited to humans, and effects on wildlife 
from contaminated water supplies have been documented in both 
males and females of multiple species (Crain et al., 2007; Mafﬁ  ni 
et al., 2006; vom Saal et al., 2007).
Although it was once thought that BPA could function as a syn-
thetic estrogen, BPA was not considered to pose a signiﬁ  cant threat 
to either wildlife or human populations because its binding afﬁ  nity 
for the primary forms of the estrogen receptor (ERα and ERβ) is 
approximately 10,000-fold weaker than that of estradiol or DES 
(Gould et al., 1998; Kuiper et al., 1998). Yet, numerous studies from 
multiple laboratories have shown that BPA can impact reproductive 
physiology and behavior in rodents at doses even lower than the 
current reference or “safe” exposure limit for humans of 50 µg/kg 
body weight per day (Vandenberg et al., 2009). The mechanism(s) 
of low dose activity remains poorly understood but has long been 
hypothesized to be most potent in hormone sensitive organs and 
brain regions when endogenous estrogens are low or absent (vom 
Saal and Moyer, 1985). Thus, like DES, at different life stages BPA 
may have profoundly different effects on the same brain region 
or organ. It may also act through nonclassical estrogen pathways 
such as those mediated via membrane ERs, GPR30 or the newly 
discovered estrogen-related receptor –γ (ERR-γ) (Matsushima et al., 
2007; Thomas and Dong, 2006; Watson et al., 2007).
Despite the controversy surrounding the mechanism by which 
low dose exposure to BPA could affect reproductive physiology, 
the evidence for widespread effects in animal models is increasing. 
Effects of perinatal exposure observed at the 50 µg/kg body weight 
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of the unconjugated (estrogenically active) form of BPA in ﬂ  uids and 
thus perhaps equally susceptible to its effects (reviewed in detail by 
Vandenberg et al., 2009). Like DDT, the fate of BPA may ultimately 
be decided by politics and public perception, rather than a regulatory 
action based on a measured evaluation of the scientiﬁ  c evidence. 
As this manuscript went to press (May, 2009) Canada declared BPA 
a “toxin” and Minnesota became the ﬁ  rst state to ban the use of 
BPA in baby bottles and cups. Many other states had similar laws 
pending. In October of 2008, the Food and Drug Administration 
reafﬁ  rmed its conclusion that BPA use in food containers does not 
pose a public health threat, a decision that was met with considerable 
criticism. Not long after, Nalgene and most baby bottle manufactur-
ers announced that they would no longer use BPA in the manufac-
turing of their products and bottles labeled “BPA-Free” are becoming 
increasingly common in Wal-Mart and other retail outlets.
ENDOCRINE DISRUPTION OF MALE REPRODUCTIVE 
PHYSIOLOGY BY DDT AND THE PHTHALATES
Endocrine disruption can also happen in males. One of the most 
notable wildlife cases has been documented by researchers at the 
University of Florida who discovered numerous genital malforma-
tions, poor hatching success, and a sex ratio heavily skewed towards 
females among alligators living in a polluted central Florida lake. 
This lake had become heavily contaminated with DDT, difocol, 
their metabolites, and other pesticides as the result of an indus-
trial spill (Guillette et al., 1994, 1995b; Milnes et al., 2005; Semenza 
et al., 1997). In mammals and birds, gonadal differentiation (the 
development of either an ovary or testis) is determined by the sex 
chromosomes. In non-mammalian vertebrates, including reptiles, 
incubation temperature during a critical window midway through 
development, inﬂ  uences which gonad forms and thus the sex of 
the animal. Guillette and colleagues discovered that exposure to 
estrogens or estrogenic EDCs can override or interact with this 
effect of temperature resulting in intersex individuals, males with 
abnormally low plasma testosterone levels, genital abnormalities, 
and malformation of the gonads (in both sexes). Exposing turtle 
or alligator eggs experimentally with the DDT metabolite DDE or 
estradiol induced similar effects (Bergeron et al., 1994; Crews et al., 
1995; Gale et al., 2002; Guillette et al., 1995a) conclusively dem-
onstrating that endocrine disruption of male sex determination 
and the differentiation of the male reproductive system is possible. 
Reproductive abnormalities within reptiles living on this lake per-
sist, even more than three decades after the initial spill, demonstrat-
ing that defects can impact multiple generations, particularly when 
the compounds are strongly lipophilic and have long half-lives.
In humans, there is growing evidence for, but considerable 
debate over, whether human male reproductive health is truly 
declining, and whether EDCs play any role in the perceived decline. 
In 1992, Carlsen and colleagues conducted a comprehensive review 
of the literature on human semen quality. Their systematic analysis 
of 61 published papers, incorporating data collected from nearly 
15,000 men, revealed a statistically signiﬁ  cant decline in mean 
seminal volume and sperm concentration over the last 50 years 
(Carlsen et al., 1992). This ﬁ  nding was widely publicized in the 
media and subsequently replicated by other investigators, although 
there appear to be signiﬁ  cant regional differences in the severity 
of the effect (Swan et al., 2000, 2003). Similarly, the incidence of 
 testicular cancer and congenital abnormalities such as hypospadias 
and cryptorchidism also appear to be increasing (Adami et al., 1994; 
SEER, 2003; Sharpe, 2003) signifying a comprehensive decline in 
male reproductive health over the past 50 years. Doubt over the 
conclusions from these analyses persist however, because reliance 
on historical data sets (retrospective studies) restricts the ability to 
control for differences in data collection methods. With this caveat 
in mind, one feature of the semen data that stands out is an apparent 
birth cohort effect, with younger generations having poorer semen 
quality than older generations (Irvine, 1994). This suggests that 
insult in fetal life could be responsible for the defects that emerge 
later. This hypothesis is supported by epidemiological data showing 
that the occurrence of one disorder, such as low sperm count, is a 
risk factor for the occurrence of another, such as testicular cancer. 
This relationship has led a Danish research group to propose that 
low sperm counts, hypospadias, cryptorchidism and testicular germ 
cell cancer are interrelated disorders, all of which have their roots in 
fetal development, comprising a “testicular dysgenesis syndrome” 
(TDS) (Boisen et al., 2001; Skakkebaek et al., 2001, 2006). The 
TDS hypothesis proposes that these disorders are all manifesta-
tions of disturbed prenatal testicular development resulting from 
abnormal hormone synthesis or action during reproductive tract 
development.
Androgens, including testosterone, produced by the fetal testes 
are essential for the differentiation of the epididymis, vas deferens 
and the seminal vesicles from the Wolfﬁ  an ducts. Differentiation of 
the prostate and external genitalia requires 5α-dihydrotestosterone 
(DHT), the most potent androgen produced by the testis catalyzed 
from testosterone by the enzyme 5α-reductase. Failure to produce 
DHT, or sufﬁ  cient levels of DHT, can lead to poorly developed or 
malformed external genitalia. Therefore toxicants that interfere 
with 5α-reductase or the interaction of DHT with the androgen 
receptor during development can impair proper development of 
male genitalia and the prostate. For example, administration of the 
androgen receptor antagonist, ﬂ  utamide during male reproductive 
tract development induces multiple abnormalities of the exter-
nal genitalia including hypospadias and cryptorchidism in both 
rats and monkeys (Herman et al., 2000; Mylchreest et al., 1999). 
Environmental toxicants are also known to interfere with male 
genital development. One of the earliest animal studies designed 
to test the hypothesis that chemical agents could interfere with 
androgen action was conducted in 1950 using chickens. Injection 
of DDT resulted in markedly undersized testes and inhibited the 
development of the comb and wattle. It was later determined that 
DDT and its metabolites function as anti-androgens (as well as 
estrogen mimics) and compete with endogenous androgens for 
access to the androgen receptor.
One class of compounds that has recently received considerable 
attention for potentially contributing to TDS is the phthalates. There 
are many different kinds of phthalates and the two considered to 
have the greatest potential to impact male reproduction are dibutyl 
phthalate (DBP) and diethylhexyl phthalate (DEHP, Figure 1). DBP 
is used in many personal care products such as lotions, cosmetics, 
nail polish, and perfume. DEHP is primarily used as a plasticizer 
in the production of ﬂ  exible products including vinyl, medical tub-
ing and toys. Infants in neonatal intensive care units have some of 
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a result of exposure through medical tubing and devices (Calafat 
et al., 2004; Weuve et al., 2006). A series of studies conducted in rats 
in the late 1990s was the ﬁ  rst to demonstrate that phthalates could 
interfere with the ability of testosterone to masculinize the male 
reproductive tract. Exposure in utero, when the genitals are being 
formed, resulted in a number of genital malformations including 
hypospadias and hemorrhagic testes (Gray et al., 1999; Wolf et al., 
2000). Thus it is plausible that neonatal exposure to phthalates 
could induce TDS. Interestingly, the phthalates do not produce 
their effects by antagonizing the androgen receptor, but rather 
by interfering with the production of androgens in the fetal testis 
(David, 2006). Exposure to phthalates during human pregnancy has 
now been associated with smaller (feminized) anogenital distance 
in infant boys (Swan et al., 2005). Epidemiological evidence has 
also positively correlated higher urinary phthalate levels with lower 
sperm counts and an increased likelihood of sperm with damaged 
DNA in adult men (Duty et al., 2003; Hauser, 2008; Pant et al., 
2008; Wirth et al., 2008). Although it is important to keep in mind 
that correlation does not prove causation, these newly emerging 
epidemiology studies are the best evidence to data that phthalates 
have the potential to affect male reproductive health in humans.
MIXTURE EFFECTS: WHEN THE QUALITY OF BIRD SONG 
CONSTITUTES “FALSE ADVERTISING”
Intriguingly, exposure to EDCs can also enhance the masculi-
nization of some traits but this many not translate to improved 
reproductive ﬁ  tness. A good example of this occurred in song 
birds exposed to a mixture of compounds including phthalates. 
In song birds, song production is controlled by discrete neural 
pathways which develop and operate under the inﬂ  uence of ster-
oid hormones. Estrogens, as well as androgens to some degree, 
are essential for proper sex speciﬁ  c organization of the song sys-
tem. According to sexual selection theory, male secondary sex 
characteristics, including the production of elaborate songs, have 
evolved as indicators of male quality and in response to female 
preferences. Thus, modiﬁ  cation of the song system by exposure 
to estrogenic contaminants could affect song quality and, as a 
result, how attractive exposed males are to potential mates. A 
recent experiment by Markman and colleagues tested this hypoth-
esis using European starlings (Sturnus vulgaris) (Markman et al., 
2008). The research group ﬁ  rst observed the foraging habits of 
wild starlings at 20 sewage treatment sites and determined that 
earthworms were a primary prey species. Subsequent analysis of 
these earthworms revealed that they were heavily contaminated 
with 17β-estradiol (E2, from human wastewater), phthalates and 
BPA. A daily exposure for each compound was then estimated. 
Wild-caught juvenile birds were then maintained in the labora-
tory and exposed to either vehicle, 200 ng E2 or the environmen-
tally relevant mixture (200 ng E2, 640 ng phthalates, 80 ng BPA) 
daily by injecting each preparation into a mealworm. The birds 
were exposed from October to April, when foraging on sewage 
beds is common, prior to the onset of the breeding season in the 
spring. Males exposed to the mixture had signiﬁ  cantly enhanced 
song production including a more complex song repertoire, an 
increased number of song bouts, and longer songs. This was 
accompanied by enlargement of an important song nucleus, the 
HVC, in the males fed the mixture compared to control males. 
Females preferred the song of males fed the mixture to males fed 
either the vehicle or the E2 alone.
Enhanced song production, however, in this case appears to be 
a false indicator of male quality because subsequent analysis found 
that, even though circulating androgen levels were comparable to 
controls, the males fed the mixture were immunocompromised. 
Thus, although EDCs enhanced the masculinization of the song 
system, by misleading females into choosing less ﬁ  t males the effect 
could subsequently decrease the overall ﬁ  tness of the population.
Interestingly, males fed only E2 did not show enhanced song 
production or larger song nuclei demonstrating that this compo-
nent of the mixture was insufﬁ  cient on its own to inﬂ  uence this 
estrogen sensitive behavior. This ﬁ  nding emphasizes the concern 
that although some estrogenic compounds may not produce effects 
at low levels on their own, they may ultimately contribute to disrup-
tion when contained within a mixture of compounds with similar 
mechanisms of action. This concern is potentially considerable 
for a number of reasons. Perhaps one of the most worrisome is 
that, because most laboratory animal diets are derived from soy 
and therefore contain relatively high levels of genistein and other 
phytoestrogens (actual amounts vary from batch to batch) this 
background of EDC exposure could impact endocrine disruption 
research (Brown and Setchell, 2001; Degen et al., 2002). Could this 
be a signiﬁ  cant potential confound? A research group at Washington 
State University recently reported that they could not replicate pre-
viously published BPA effects in the mouse ovary. They ultimately 
concluded that effects were only observed in mice maintained on 
soy-rich diets leading the authors to hypothesize that diet, along 
with methodological differences, could explain why the literature 
surrounding “low dose” effects of BPA is fragmented and inconsist-
ent (Muhlhauser et al., 2009). The concept of mixture effects is an 
evolving area of endocrine disruption research, the results of which 
could have profound implications for other disciplines including 
neuroendocrinology and behavioral biology.
TRANSGENERATIONAL EFFECTS AND THE EMERGING FIELD 
OF EPIGENETICS
It is now becoming evident that the effects of EDC exposure are not 
necessarily limited to the exposed individual. Many of these com-
pounds are now recognized to have transgenerational effects and 
in some cases the effects within subsequent generations are more 
profound than those seen in the ﬁ  rst generation (Jirtle and Skinner, 
2007; Steinberg et al., 2008). For example, there is emerging concern 
that the children of DES daughters (referred to as DES grand-
daughters) might also experience reproductive problems. For these 
girls, their exposure occurred when they were germ cells in their 
mother’s developing ovary, within the womb of their grandmother. 
If true, it would be the ﬁ  rst instance in humans which conclusively 
demonstrates that persistent, generational effects can result from 
an in utero exposure to a potent estrogen (Newbold et al., 1998). 
This concern for DES granddaughters arose from data obtained 
in laboratory animal studies which indicated that the offspring of 
females exposed in utero were more likely to develop reproductive 
tract lesions than unexposed control animals (Newbold et al., 1998, 
2000). Other studies have produced evidence that DES effects across 
generations can be transmitted through the paternal line as well 
(Walker and Haven, 1997). So far, there is not enough human data Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  12
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to indicate a trend for deleterious effects in DES granddaughters, 
largely because this cohort is so young. Continued monitoring of 
these women as they age will ultimately be required to determine 
if there are transgenerational effects of prenatal DES exposure in 
humans.
The precise mechanisms through which endocrine disrupting 
effects transmit to subsequent generations are not well understood 
but emerging evidence indicates alteration of chromosomal struc-
ture or other epigenetic mechanisms might be the primary method. 
Epigenetic inheritance involves changes in gene expression pat-
terns without changes in gene sequence. Such effects include DNA 
methylation and histone modiﬁ  cations, among others. In most 
cases, methylation of gene promoter regions abrogates gene tran-
scription while acetylation of the histone tail enhances it (Dolinoy 
et al., 2007; Gore, 2008; Ho and Tang, 2007). These processes can 
be inﬂ  uenced by environmental factors and if these modiﬁ  cations 
occur within the germ cell lines then transmission to subsequent 
generations is possible (Giusti et al., 1995; Gore, 2008; Jirtle and 
Skinner, 2007). This newly discovered and evolving area of research 
has once again transformed the ﬁ  eld of toxicology and introduced 
a novel method by which endocrine disruptors and other toxicants 
can affect vertebrate physiology and behavior.
A well characterized animal model demonstrating the potential 
for epigenetic modiﬁ  cations to impact future generations involves 
the manipulation of the murine agouti gene in a specialized mouse 
strain (Duhl et al., 1994; Vrieling et al., 1994). In this strain, the 
degree of methylation on an inserted transposable element can vary 
dramatically and correlates with a wide distribution in coat color 
that ranges from yellow (unmethylated) to brown (methylated) 
as well as the occurrence of diabetes, obesity and tumorigenesis. 
Maternal dietary supplementation of methyl-donors (folic acid, 
vitamin B12, choline and betaine) during pregnancy can shift the 
coat color of offspring towards the brown pseudoagouti pheno-
type (Duhl et al., 1994; Waterland and Jirtle, 2003; Wolff et al., 
1998) demonstrating the effect maternal diet can have on offspring 
adult phenotypes. Even more intriguing is the observation that 
maternal exposure to genistein induces hypermethylation, again 
shifting the coat color of the offspring to brown (Dolinoy et al., 
2006), but unlike other methyl donors, genistein protected these 
offspring from the obesity normally associated with the darker 
color. These results illustrate the potential for genistein and perhaps 
other EDCs to epigenetically alter the phenotype of subsequent gen-
erations through in utero exposure. Other compounds, including 
polychlorinated biphenyls (PCBs) (Aubrecht et al., 1995; Schiestl 
et al., 1997) and the fungicide vinclozolin (Anway et al., 2006; Gore, 
2008) have also been shown to produce transgenerational effects, 
perhaps through epigenetic mechanisms.
When a pregnant animal is exposed to an EDC, it is important 
to keep in mind that the mother (F0), the embryo (F1) and the F2 
generation (as germ cells) are all directly exposed. While the majority 
of studies concerning transgenerational epigenetic effects of EDCs 
have not been carried past the F2 generation it is important to note 
that, to rule out direct exposure effects, the F3 generation should also 
be examined for abnormalities. It is also critical to appreciate that 
epigenetic effects can also occur outside of the germ line. Thus these 
mechanisms may underlie many observed EDC effects and could 
explain how compounds which are only weakly estrogenic, like BPA, 
can produce appreciable, lasting results at such low levels (Jirtle and 
Skinner, 2007). The ability of most estrogenic EDCs, such as DES, 
genistein and BPA, to pass from mother to offspring through placental 
blood ﬂ  ow or lactational transfer makes the possibility for epigenetic, 
transgenerational effects likely (Crews and McLachlan, 2006; Franke 
and Custer, 1996; Mably et al., 1992; Newbold, 2006; Ruden et al., 
2005; Sun et al., 2004; Wisniewski et al., 2003). Although the speciﬁ  c 
mechanisms underlying the observed transgenerational effects of 
DES in animals have proven difﬁ  cult to elucidate, emerging research 
implicates epigenetic modiﬁ  cations as a signiﬁ  cant component (Gore, 
2008; Li et al., 2003; Newbold, 2006). Newbold and colleagues have 
recently shown that alterations in gene methylation patterns of estro-
gen-responsive genes following DES exposure can be passed on to 
the next generation (Li et al., 1997, 2003; Newbold, 2006). Studies 
exploring how epigenetics might explain the “fetal origins of adult 
disease” are currently underway in DES granddaughters, but results 
will emerge slowly because of the relatively young age of the subjects. 
Although clear indicators of illness occurred early in some individu-
als, most carcinogenic and reproductive tract abnormalities in DES 
daughters did not occur until at least middle age and it will be another 
decade before most of the DES granddaughters reach that age as well. 
Thus, many transgenerational effects in these individuals have likely 
not yet emerged (Giusti et al., 1995; Rubin, 2007).
CONCLUSIONS
While it appears clear, in both animals and humans, that exposure 
to EDCs can have adverse effects on reproductive physiology and 
behavior, controversies surrounding this topic remain. Importantly, 
recognition of the prevalence of these compounds in the environ-
ment and their potential to adversely affect both wildlife and human 
populations is increasing among scientists, policy makers, and the 
general public. Further efforts to understand the mechanisms 
underlying EDC effects, particularly those seen at environmen-
tally relevant doses by compounds with low hormonal potency, are 
necessary to adequately develop a public health strategy for prevent-
ing or combating their effects. The ability of these compounds to 
permanently affect the epigenome could be potentially catastrophic 
to the welfare of future generations and requires further attention 
by both toxicologists and endocrinologists. While research sur-
rounding this topic is not conclusive, particularly in humans, there 
is certainly sufﬁ  cient evidence to warrant concern about potential 
long term effects in both wildlife and humans. Obtaining absolute 
proof of endocrine disruption by BPA, phthalates, and other com-
pounds with weak hormonal activity in humans is likely impossible 
because it would obviously be unethical to conduct a double-blind 
study where one group is exposed to a suspected toxicant. Research 
in animals, however, is robust and indicates that disruption of sex 
speciﬁ  c behavior, neuroendocrine circuitry and physiology is pos-
sible and, in some cases, transgenerational.
Unfortunately, it is extraordinarily difﬁ  cult for individuals 
to make informed choices about how to reduce their potential 
exposure because chemicals in the US are not routinely screened 
or tested for endocrine disrupting properties. The Endocrine 
Disruptor Screening and Testing Advisory Committee (EDSTAC) 
was formed by Congress in 1996 to make speciﬁ  c recommendations 
to the EPA about how to test and screen compounds for endocrine 
disrupting properties, but progress has been   frustratingly slow. Frontiers in Behavioral Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 10  |  13
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